We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$9.86M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.7M
3
CNR
Core Natural Resources Inc
CNR
+$8.26M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$6.63M
5
ORCL icon
Oracle
ORCL
+$6.25M

Top Sells

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$14M
2
HTLF
Heartland Financial USA, Inc.
HTLF
+$11.1M
3
NVDA icon
NVIDIA
NVDA
+$9.36M
4
AMZN icon
Amazon
AMZN
+$8.75M
5
NFLX icon
Netflix
NFLX
+$8.58M

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S icon
551
SentinelOne
S
$7.62B
$441K 0.03%
+24,275
New +$527K
CAH icon
552
Cardinal Health
CAH
$55.5B
$441K 0.03%
+3,199
New +$408K
FLS icon
553
Flowserve
FLS
$10.1B
$440K 0.03%
9,001
-23,148
-72% -$1.31M
BNDX icon
554
Vanguard Total International Bond ETF
BNDX
$82.8B
$439K 0.03%
+8,990
New +$440K
WBD icon
555
Warner Bros
WBD
$67.4B
$438K 0.03%
40,865
+12,990
+47% +$136K
PZZA icon
556
Papa John's
PZZA
$785M
$438K 0.03%
+10,662
New +$456K
HIMS icon
557
Hims & Hers Health
HIMS
$7.35B
$437K 0.03%
14,795
-2,009
-12% -$74.6K
LVS icon
558
Las Vegas Sands
LVS
$29.4B
$437K 0.03%
+11,304
New +$499K
CRNX icon
559
Crinetics Pharmaceuticals
CRNX
$8.93B
$435K 0.03%
+12,959
New +$484K
BE icon
560
Bloom Energy
BE
$62B
$434K 0.03%
22,090
+10,182
+86% +$243K
CME icon
561
CME Group
CME
$94.8B
$434K 0.03%
1,635
+46
+3% +$11.3K
PRIM icon
562
Primoris Services
PRIM
$4.35B
$433K 0.03%
+7,545
New +$546K
TSM icon
563
PUT
TSMC
TSM
$2.17T
$432K 0.03%
2,600
+600
+30% +$117K
EWZS icon
564
iShares MSCI Brazil Small-Cap ETF
EWZS
$218M
$431K 0.03%
+40,000
New +$413K
MATX icon
565
Matsons
MATX
$6.24B
$429K 0.03%
3,350
+507
+18% +$69.5K
MELI icon
566
Mercado Libre
MELI
$92.5B
$429K 0.03%
220
-38
-15% -$75.4K
CRBP icon
567
Corbus Pharmaceuticals
CRBP
$177M
$427K 0.03%
+80,347
New +$709K
TDS icon
568
CALL
Telephone and Data Systems
TDS
$3.84B
$422K 0.03%
10,900
– –
NWSA icon
569
News Corp Class A
NWSA
$15.4B
$421K 0.03%
15,464
-40,395
-72% -$1.13M
CDRE icon
570
Cadre Holdings
CDRE
$1.4B
$416K 0.03%
+14,055
New +$484K
RH icon
571
RH
RH
$3.47B
$416K 0.03%
1,774
+837
+89% +$290K
GOSS icon
572
Gossamer Bio
GOSS
$86.1M
$414K 0.03%
376,802
-38,045
-9% -$44K
BAC icon
573
Bank of America
BAC
$447B
$414K 0.03%
+9,915
New +$442K
SII
574
Sprott
SII
$2.97B
$414K 0.03%
9,218
+537
+6% +$23.1K
ZBRA icon
575
Zebra Technologies
ZBRA
$17.9B
$411K 0.03%
1,456
+528
+57% +$180K
21 22
23
24 25

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.